SeaStar Medical Holding Corporation
ICU
$0.31
$0.00-0.48%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 169.12% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 169.12% | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 148.53% | -- | -- | -- | -- |
| SG&A Expenses | -13.25% | -55.89% | -25.26% | 6.84% | 17.95% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.84% | -55.15% | 4.18% | 54.11% | 53.77% |
| Operating Income | 19.68% | 62.39% | 3.24% | -51.97% | -51.46% |
| Income Before Tax | 22.47% | 38.08% | 70.32% | 53.30% | 38.08% |
| Income Tax Expenses | -- | -- | -- | 100.00% | -- |
| Earnings from Continuing Operations | 22.47% | 38.13% | 70.29% | 53.27% | 38.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 22.47% | 38.13% | 70.29% | 53.27% | 38.08% |
| EBIT | 19.68% | 62.39% | 3.24% | -51.97% | -51.46% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 88.00% | 82.77% | 90.75% | 85.34% | 87.85% |
| Normalized Basic EPS | 88.00% | 82.76% | 90.76% | 85.65% | 61.51% |
| EPS Diluted | 88.00% | 82.77% | 90.75% | 85.34% | 87.85% |
| Normalized Diluted EPS | 88.00% | 82.76% | 90.76% | 85.65% | 61.51% |
| Average Basic Shares Outstanding | 545.80% | 259.12% | 221.06% | 218.69% | 409.65% |
| Average Diluted Shares Outstanding | 545.80% | 259.12% | 221.06% | 218.69% | 409.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |